Nrf2 as a Potential Therapeutic Target for Traumatic Brain Injury

In this review, we discuss the possibility and feasibility of nuclear factor erythroid 2-related factor 2 (Nrf2) as a therapeutic target to minimize the devastating effects of a brain injury. To complete this review, comprehensive literature searches were conducted in MEDLINE, PubMed, Embase, and Ps...

Full description

Bibliographic Details
Main Author: P. M. Abdul-Muneer
Format: Article
Language:English
Published: IMR Press 2023-06-01
Series:Journal of Integrative Neuroscience
Subjects:
Online Access:https://www.imrpress.com/journal/JIN/22/4/10.31083/j.jin2204081
_version_ 1797768993947254784
author P. M. Abdul-Muneer
author_facet P. M. Abdul-Muneer
author_sort P. M. Abdul-Muneer
collection DOAJ
description In this review, we discuss the possibility and feasibility of nuclear factor erythroid 2-related factor 2 (Nrf2) as a therapeutic target to minimize the devastating effects of a brain injury. To complete this review, comprehensive literature searches were conducted in MEDLINE, PubMed, Embase, and PsycINFO databases for English scientific peer-reviewed articles through December 2022. This short review addressed the different sources of oxidative stress and its effects on blood-brain barrier (BBB) dysfunction, mitochondrial damage, and changes in a variety of inflammatory molecules associated with central nervous system (CNS) injury. At last, we explained the potential efficacy of the Nrf2 transcription factor in reducing oxidative stress-mediated secondary damages after a CNS injury. The role of CPUY192018, an inhibitor of Nrf2-Keap1 protein-protein interaction in protecting the injured brain cells is given as evidence of Nrf2’s role in activating antioxidant genes. Overall, the scope of Nrf2 in developing therapeutic interventions for a variety of pathophysiological conditions associated with CNS injury-induced free radical/inflammatory signaling is acknowledged. Nrf2 has a widespread application in basic and clinical neuroscience for understanding and treating free radical/inflammatory signaling disorders, including neurological diseases. The development of innovative therapeutic strategies using Nrf2-inducing agents can be applied to reduce the complications of TBI before advancing it to posttraumatic stress disorder (PTSD).
first_indexed 2024-03-12T21:01:27Z
format Article
id doaj.art-d346d7b779384a5fa547c65c19de505d
institution Directory Open Access Journal
issn 0219-6352
language English
last_indexed 2024-03-12T21:01:27Z
publishDate 2023-06-01
publisher IMR Press
record_format Article
series Journal of Integrative Neuroscience
spelling doaj.art-d346d7b779384a5fa547c65c19de505d2023-07-31T07:12:12ZengIMR PressJournal of Integrative Neuroscience0219-63522023-06-012248110.31083/j.jin2204081S0219-6352(23)00539-9Nrf2 as a Potential Therapeutic Target for Traumatic Brain InjuryP. M. Abdul-Muneer0Laboratory of CNS Injury and Molecular Therapy, JFK Neuroscience Institute, Hackensack Meridian JFK University Medical Center, Edison, NJ 08820, USAIn this review, we discuss the possibility and feasibility of nuclear factor erythroid 2-related factor 2 (Nrf2) as a therapeutic target to minimize the devastating effects of a brain injury. To complete this review, comprehensive literature searches were conducted in MEDLINE, PubMed, Embase, and PsycINFO databases for English scientific peer-reviewed articles through December 2022. This short review addressed the different sources of oxidative stress and its effects on blood-brain barrier (BBB) dysfunction, mitochondrial damage, and changes in a variety of inflammatory molecules associated with central nervous system (CNS) injury. At last, we explained the potential efficacy of the Nrf2 transcription factor in reducing oxidative stress-mediated secondary damages after a CNS injury. The role of CPUY192018, an inhibitor of Nrf2-Keap1 protein-protein interaction in protecting the injured brain cells is given as evidence of Nrf2’s role in activating antioxidant genes. Overall, the scope of Nrf2 in developing therapeutic interventions for a variety of pathophysiological conditions associated with CNS injury-induced free radical/inflammatory signaling is acknowledged. Nrf2 has a widespread application in basic and clinical neuroscience for understanding and treating free radical/inflammatory signaling disorders, including neurological diseases. The development of innovative therapeutic strategies using Nrf2-inducing agents can be applied to reduce the complications of TBI before advancing it to posttraumatic stress disorder (PTSD).https://www.imrpress.com/journal/JIN/22/4/10.31083/j.jin2204081nrf2oxidative stressreactive oxygen speciesantioxidantsbrain injuryblood-brain barrierantioxidant response elements
spellingShingle P. M. Abdul-Muneer
Nrf2 as a Potential Therapeutic Target for Traumatic Brain Injury
Journal of Integrative Neuroscience
nrf2
oxidative stress
reactive oxygen species
antioxidants
brain injury
blood-brain barrier
antioxidant response elements
title Nrf2 as a Potential Therapeutic Target for Traumatic Brain Injury
title_full Nrf2 as a Potential Therapeutic Target for Traumatic Brain Injury
title_fullStr Nrf2 as a Potential Therapeutic Target for Traumatic Brain Injury
title_full_unstemmed Nrf2 as a Potential Therapeutic Target for Traumatic Brain Injury
title_short Nrf2 as a Potential Therapeutic Target for Traumatic Brain Injury
title_sort nrf2 as a potential therapeutic target for traumatic brain injury
topic nrf2
oxidative stress
reactive oxygen species
antioxidants
brain injury
blood-brain barrier
antioxidant response elements
url https://www.imrpress.com/journal/JIN/22/4/10.31083/j.jin2204081
work_keys_str_mv AT pmabdulmuneer nrf2asapotentialtherapeutictargetfortraumaticbraininjury